Boxer Capital, LLC Kinnate Biopharma Inc. Transaction History

Boxer Capital, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$2.33 - $6.84 $44,270 - $129,960	-19,000 Reduced 3.73%	491,000 $1.49 Million
Q4 2022 Feb 14, 2023	SELL	$5.26 - $12.19 $5.33 Million - $12.3 Million	-1,012,559 Reduced 66.5%	510,000 $3.11 Million
Q3 2022 Nov 14, 2022	SELL	$9.86 - $15.76 $3.2 Million - $5.12 Million	-325,000 Reduced 17.59%	1,522,559 $18.2 Million
Q3 2021 Nov 15, 2021	BUY	$17.81 - $24.87 $13.9 Million - $19.4 Million	781,620 Added 73.33%	1,847,559 $42.5 Million
Q1 2021 May 17, 2021	BUY	$26.99 - $40.0 $34,385 - $50,960	1,274 Added 0.12%	1,065,939 $33.2 Million

Q4 2020 Feb 16, 2021	BUY	$36.35 - $45.25 $38.7 Million - $48.2 Million	1,064,665 New	1,064,665 $42.4 Million

32.9M

94.7K

802K

Ticker KNTE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 44,145,600
Description
Kinnate Biopharma Inc., a biopharmaceutical company, focuses on the discovery and development of small molecule kinase inhibitors to treat genomically defined cancers in the United States. The company develops KIN-2787, a rapidly accelerated fibrosarcoma inhibitor for the treatment of patients with lung cancer, melanoma, and other solid tumors; ...

Get notified when there are updates to the investment portfolio of Boxer Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Boxer Capital, LLC with notifications on news.